Roche
ROG.SW
#37
Rank
NZ$575.29 B
Marketcap
NZ$717.10
Share price
1.38%
Change (1 day)
48.38%
Change (1 year)

Market capitalization of Roche (ROG.SW)

Market cap: NZ$575.29 Billion

As of December 2025 Roche has a market cap of NZ$575.29 Billion. This makes Roche the world's 37th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Roche from 2006 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$575.29 B43.82%
2024NZ$400.02 B8.08%
2023NZ$370.09 B-9.47%
2022NZ$408.80 B-22.36%
2021NZ$526.52 B26.97%
2020NZ$414.68 B1.06%
2019NZ$410.33 B30.67%
2018NZ$314.02 B3.8%
2017NZ$302.54 B7.06%
2016NZ$282.58 B-18.88%
2015NZ$348.34 B17.82%
2014NZ$295.66 B2.02%
2013NZ$289.80 B-24.43%
2012NZ$383.47 B103.16%
2011NZ$188.75 B14.26%
2010NZ$165.19 B-19.39%
2009NZ$204.94 B-12.12%
2008NZ$233.21 B17.91%
2007NZ$197.78 B-9.83%
2006NZ$219.35 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$859.88 B 49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$456.71 B-20.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$244.45 B-57.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$201.25 B-65.02%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$457.73 B-20.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$170.20 B-70.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Abbott Laboratories
ABT
NZ$373.13 B-35.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$308.89 B-46.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$96.15 B-83.29%๐Ÿ‡บ๐Ÿ‡ธ USA